Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence
S Rahman, MTV Montero, K Rowe… - Expert review of …, 2021 - Taylor & Francis
Introduction The COVID-19 pandemic has created a public health crisis, infected millions of
people, and caused a significant number of deaths. SARS-CoV-2 transmits from person to …
people, and caused a significant number of deaths. SARS-CoV-2 transmits from person to …
The role and therapeutic potential of NF-kappa-B pathway in severe COVID-19 patients
A Hariharan, AR Hakeem, S Radhakrishnan… - …, 2021 - Springer
Abstract Coronavirus disease 2019 (COVID-19) pandemic has affected health care systems
worldwide. Severe presentations of COVID-19 such as severe pneumonia and acute …
worldwide. Severe presentations of COVID-19 such as severe pneumonia and acute …
[PDF][PDF] Therapeutics and COVID-19: living guideline, 13 January 2023
World Health Organization - 2023 - apps.who.int
As of December 2022, there have been over 642 million confirmed cases of COVID-19 (10).
The pandemic has thus far claimed approximately 6.62 million lives (10). Vaccination is …
The pandemic has thus far claimed approximately 6.62 million lives (10). Vaccination is …
Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial
Importance Evidence regarding corticosteroid use for severe coronavirus disease 2019
(COVID-19) is limited. Objective To determine whether hydrocortisone improves outcome for …
(COVID-19) is limited. Objective To determine whether hydrocortisone improves outcome for …
[PDF][PDF] A living WHO guideline on drugs for covid-19
The evidence base for therapeutics for covid-19 is evolving with numerous randomised
controlled trials (RCTs) recently completed and under way. This update adds new …
controlled trials (RCTs) recently completed and under way. This update adds new …
Vitamin D and survival in COVID-19 patients: A quasi-experimental study
C Annweiler, B Hanotte, CG de l'Eprevier… - The Journal of steroid …, 2020 - Elsevier
Vitamin D may be a central biological determinant of COVID-19 outcomes. The objective of
this quasi-experimental study was to determine whether bolus vitamin D3 supplementation …
this quasi-experimental study was to determine whether bolus vitamin D3 supplementation …
Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis
D Chaudhuri, K Sasaki, A Karkar, S Sharif… - Intensive care …, 2021 - Springer
Purpose Corticosteroids are now recommended for patients with severe COVID-19 including
those with COVID-related ARDS. This has generated renewed interest regarding whether …
those with COVID-related ARDS. This has generated renewed interest regarding whether …
Impact of corticosteroids in coronavirus disease 2019 outcomes: systematic review and meta-analysis
Background Since its appearance in late 2019, infections caused by severe acute
respiratory syndrome coronavirus 2 have created unprecedented challenges for health …
respiratory syndrome coronavirus 2 have created unprecedented challenges for health …
COVID-19: Advances in diagnostic tools, treatment strategies, and vaccine development
An unprecedented worldwide spread of the SARS-CoV-2 has imposed severe challenges
on healthcare facilities and medical infrastructure. The global research community faces …
on healthcare facilities and medical infrastructure. The global research community faces …
[PDF][PDF] Corticosteroids for COVID-19: living guidance, 2 September 2020
World Health Organization - 2020 - apps.who.int
Untitled Page 1 Page 2 糖皮质激素用于治疗 2019 冠状 病毒病(COVID-19) 活的指导 2020 年
9 月 2 日 WHO reference number: WHO/2019-nCoV/Corticosteroids/2020.1 © 世界卫生组织 …
9 月 2 日 WHO reference number: WHO/2019-nCoV/Corticosteroids/2020.1 © 世界卫生组织 …